Dynamics of < smlcap > L < /smlcap > -Carnitine in Plasma and Urine in Patients Undergoing Cisplatin Chemotherapy

Conclusions: CDDP transiently increased plasma LC levels. The mechanism seemed to involve recruitment for marked urinary loss of LC. However, these changes in plasma and urinary LC levels were not related to clinical factors, suggesting that the dynamics of LC were independent of preexisting physical parameters.Chemotherapy 2017;62:225-230

Source: Chemotherapy - April 18, 2017 Category: Cancer & Oncology Source Type: research